These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 21722606

  • 1. Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis.
    Bitencourt Dias C, Pinheiro CC, Malafronte P, Titan S, Alves de Brito G, Gera Abrão J, Dos Santos Silva V, Toledo Barros R, Woronik V.
    Clin Nephrol; 2011 Jul; 76(1):57-63. PubMed ID: 21722606
    [Abstract] [Full Text] [Related]

  • 2. Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression.
    Chan TM, Li FK, Hao WK, Chan KW, Lui SL, Tang S, Lai KN.
    Lupus; 1999 Jul; 8(7):545-51. PubMed ID: 10483033
    [Abstract] [Full Text] [Related]

  • 3. Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study.
    Hu WX, Chen YH, Bao H, Liu ZZ, Wang SF, Zhang HT, Liu ZH.
    Lupus; 2015 Sep; 24(10):1067-75. PubMed ID: 25819933
    [Abstract] [Full Text] [Related]

  • 4. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
    Zhang M, Qi C, Zha Y, Chen J, Luo P, Wang L, Sun Z, Wan J, Xing C, Wang S, Jiang G, Sun M, Chen Q, Chen J, Li D, Guan T, Ni Z.
    Clin Rheumatol; 2019 Mar; 38(3):859-867. PubMed ID: 30426311
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population.
    Mejía-Vilet JM, Córdova-Sánchez BM, Uribe-Uribe NO, Correa-Rotter R.
    Clin Rheumatol; 2016 Sep; 35(9):2219-27. PubMed ID: 27475791
    [Abstract] [Full Text] [Related]

  • 6. Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study.
    Fischer-Betz R, Chehab G, Sander O, Vordenbäumen S, Voiculescu A, Brinks R, Schneider M.
    J Rheumatol; 2012 Nov; 39(11):2111-7. PubMed ID: 22984276
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 8. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
    Arends S, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Berden JH, Dutch Working Party on systemic lupus erythematosus.
    Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
    [Abstract] [Full Text] [Related]

  • 9. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C, Ligtenberg G, Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
    [Abstract] [Full Text] [Related]

  • 10. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study.
    Mehra S, Usdadiya JB, Jain VK, Misra DP, Negi VS.
    Rheumatol Int; 2018 Apr; 38(4):557-568. PubMed ID: 29450636
    [Abstract] [Full Text] [Related]

  • 11. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
    Arends S, Berden JH, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Dutch Working Party on SLE.
    Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
    [Abstract] [Full Text] [Related]

  • 12. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C.
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
    Matsumoto Y, Shimada Y, Nojima Y, Moriki T.
    Ren Fail; 2013 Aug; 35(7):936-41. PubMed ID: 23815417
    [Abstract] [Full Text] [Related]

  • 14. Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone.
    Chan TM, Li FK, Wong RW, Wong KL, Chan KW, Cheng IK.
    Nephron; 1995 Aug; 71(3):321-7. PubMed ID: 8569982
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases.
    Kasitanon N, Petri M, Haas M, Magder LS, Fine DM.
    Lupus; 2008 Jan; 17(1):40-5. PubMed ID: 18089682
    [Abstract] [Full Text] [Related]

  • 16. Remission of refractory lupus nephritis with a protocol including rituximab.
    Fra GP, Avanzi GC, Bartoli E.
    Lupus; 2003 Jan; 12(10):783-7. PubMed ID: 14596429
    [Abstract] [Full Text] [Related]

  • 17. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q, Li H, Xie X, Qu F, Li X, Chen J.
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R, Palomba D, Satta A, Pirisi M, Tanda F, Bartoli E.
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [Abstract] [Full Text] [Related]

  • 19. Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone.
    Bruns FJ, Adler S, Fraley DS, Segel DP.
    Ann Intern Med; 1991 May 01; 114(9):725-30. PubMed ID: 2012353
    [Abstract] [Full Text] [Related]

  • 20. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
    Ruiz-Irastorza G, Ugarte A, Saint-Pastou Terrier C, Lazaro E, Iza A, Couzi L, Saenz R, Richez C, Porta S, Blanco P.
    Autoimmun Rev; 2017 Aug 01; 16(8):826-832. PubMed ID: 28564619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.